| TNF signaling pathway |
2.98 |
0.00e+0 |
103/112 (91.96%) |
VCAM1;NFKBIA;BIRC3;...
|
| Viral protein interaction with cytokine and cytokine re... |
2.64 |
0.00e+0 |
84/100 (84%) |
CXCL8;CXCL1;CXCL2;...
|
| NF-kappa B signaling pathway |
2.62 |
0.00e+0 |
90/104 (86.54%) |
RELB;VCAM1;NFKBIA;...
|
| IL-17 signaling pathway |
2.57 |
0.00e+0 |
84/94 (89.36%) |
NFKBIA;CXCL8;MMP1;...
|
| Rheumatoid arthritis |
2.51 |
0.00e+0 |
78/93 (83.87%) |
CXCL8;LTB;MMP1;...
|
| Cytokine-cytokine receptor interaction |
2.35 |
0.00e+0 |
246/295 (83.39%) |
CXCL8;LTB;IL32;...
|
| Epstein-Barr virus infection |
2.31 |
0.00e+0 |
189/202 (93.56%) |
RELB;NFKBIA;TNFAIP3;...
|
| Herpes simplex virus 1 infection |
2.25 |
0.00e+0 |
165/498 (33.13%) |
NFKBIA;BIRC3;IKBKE;...
|
| NOD-like receptor signaling pathway |
2.23 |
0.00e+0 |
145/181 (80.11%) |
NFKBIA;BIRC3;CXCL8;...
|
| Legionellosis |
2.23 |
0.00e+0 |
51/57 (89.47%) |
NFKBIA;HSPA8;CXCL8;...
|
| Th1 and Th2 cell differentiation |
2.22 |
0.00e+0 |
80/92 (86.96%) |
NFKBIA;NFKB1;NOTCH2;...
|
| Influenza A |
2.19 |
0.00e+0 |
156/172 (90.7%) |
NFKBIA;CXCL8;CXCL10;...
|
| Th17 cell differentiation |
2.19 |
0.00e+0 |
95/107 (88.79%) |
NFKBIA;IL27RA;NFKB1;...
|
| Proteasome |
2.18 |
0.00e+0 |
44/46 (95.65%) |
PSMC2;PSMA2;PSMD12;...
|
| Human T-cell leukemia virus 1 infection |
2.18 |
0.00e+0 |
197/219 (89.95%) |
RELB;NFKBIA;NFKB1;...
|
| C-type lectin receptor signaling pathway |
2.17 |
0.00e+0 |
93/104 (89.42%) |
RELB;NFKBIA;IKBKE;...
|
| Antigen processing and presentation |
2.16 |
0.00e+0 |
60/78 (76.92%) |
HSPA8;CTSS;TAPBP;...
|
| Measles |
2.15 |
0.00e+0 |
133/139 (95.68%) |
NFKBIA;HSPA8;TNFAIP3;...
|
| Toll-like receptor signaling pathway |
2.15 |
0.00e+0 |
94/104 (90.38%) |
NFKBIA;CXCL8;CXCL10;...
|
| Lipid and atherosclerosis |
2.11 |
0.00e+0 |
190/215 (88.37%) |
VCAM1;NFKBIA;HSPA8;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
2.08 |
0.00e+0 |
62/70 (88.57%) |
NFKBIA;CXCL8;CXCL1;...
|
| Chagas disease |
2.08 |
0.00e+0 |
93/102 (91.18%) |
NFKBIA;CXCL8;NFKB1;...
|
| Chemokine signaling pathway |
2.06 |
0.00e+0 |
163/192 (84.9%) |
NFKBIA;CXCL8;CXCL1;...
|
| Toxoplasmosis |
2.05 |
0.00e+0 |
103/112 (91.96%) |
NFKBIA;BIRC3;HSPA8;...
|
| Necroptosis |
2.04 |
0.00e+0 |
113/159 (71.07%) |
BIRC3;TNFAIP3;BIRC2;...
|
| T cell receptor signaling pathway |
2.03 |
0.00e+0 |
93/104 (89.42%) |
NFKBIA;NFKB1;PIK3CD;...
|
| Small cell lung cancer |
2.03 |
0.00e+0 |
90/92 (97.83%) |
NFKBIA;BIRC3;LAMC2;...
|
| Cytosolic DNA-sensing pathway |
1.99 |
3.88e-4 |
52/63 (82.54%) |
NFKBIA;CXCL10;IKBKE;...
|
| Ribosome biogenesis in eukaryotes |
1.97 |
3.75e-4 |
52/108 (48.15%) |
GTPBP4;IMP3;PWP2;...
|
| Pertussis |
1.96 |
3.62e-4 |
64/76 (84.21%) |
CXCL8;CXCL5;CXCL6;...
|
| Butanoate metabolism |
-1.59 |
4.77e-2 |
23/28 (82.14%) |
ACAT1;ECHS1;AACS;...
|
| Pantothenate and CoA biosynthesis |
-1.60 |
4.65e-2 |
14/21 (66.67%) |
PPCS;DPYD;BCAT1;...
|
| Mineral absorption |
-1.61 |
4.48e-2 |
48/60 (80%) |
SLC5A1;TRPV6;ATP2B4;...
|
| Glycolysis / Gluconeogenesis |
-1.61 |
4.57e-2 |
56/67 (83.58%) |
LDHC;PDHB;ADH1C;...
|
| Thermogenesis |
-1.62 |
4.47e-2 |
173/232 (74.57%) |
PRKAA1;SMARCC2;NDUFA6;...
|
| Pentose and glucuronate interconversions |
-1.63 |
4.11e-2 |
17/34 (50%) |
UGT2B15;UGT2B4;RPE;...
|
| Biosynthesis of unsaturated fatty acids |
-1.64 |
4.14e-2 |
21/27 (77.78%) |
HSD17B4;SCD;ELOVL4;...
|
| Proximal tubule bicarbonate reclamation |
-1.65 |
3.94e-2 |
21/23 (91.3%) |
ATP1A1;PCK2;FXYD2;...
|
| Oxidative phosphorylation |
-1.67 |
3.37e-2 |
93/133 (69.92%) |
ATP6V1F;NDUFA6;COX6A1;...
|
| Platelet activation |
-1.68 |
3.47e-2 |
106/124 (85.48%) |
GNAQ;GP1BB;F2R;...
|
| Protein digestion and absorption |
-1.71 |
2.19e-2 |
78/103 (75.73%) |
SLC1A5;XPNPEP2;MME;...
|
| Vascular smooth muscle contraction |
-1.73 |
1.65e-2 |
113/133 (84.96%) |
MYLK;GUCY1A1;ITPR2;...
|
| Pyruvate metabolism |
-1.75 |
1.40e-2 |
41/47 (87.23%) |
LDHC;ACACA;PDHB;...
|
| Phenylalanine metabolism |
-1.76 |
1.44e-2 |
14/17 (82.35%) |
HPD;PAH;AOC3;...
|
| Cardiac muscle contraction |
-1.80 |
1.02e-2 |
64/87 (73.56%) |
ATP2A2;COX6A1;COX8A;...
|
| Arginine biosynthesis |
-1.81 |
1.03e-2 |
17/22 (77.27%) |
GLUD2;GLUD1;OTC;...
|
| beta-Alanine metabolism |
-1.81 |
1.16e-2 |
25/30 (83.33%) |
HIBCH;DPYD;ALDH6A1;...
|
| Steroid hormone biosynthesis |
-1.81 |
1.33e-2 |
43/61 (70.49%) |
UGT2B15;HSD17B6;CYP3A5;...
|
| Ascorbate and aldarate metabolism |
-1.87 |
6.20e-3 |
15/30 (50%) |
UGT2B15;ALDH7A1;UGT2B4;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.95 |
1.86e-3 |
49/77 (63.64%) |
SULT2A1;MGST3;AKR7A3;...
|
| Fatty acid degradation |
-1.97 |
2.33e-3 |
40/43 (93.02%) |
ACSBG1;ECI2;HADHB;...
|
| Steroid biosynthesis |
-2.01 |
0.00e+0 |
19/20 (95%) |
DHCR7;NSDHL;SQLE;...
|
| Tyrosine metabolism |
-2.04 |
0.00e+0 |
30/36 (83.33%) |
ADH1C;ADH1A;DDC;...
|
| Retinol metabolism |
-2.20 |
0.00e+0 |
41/68 (60.29%) |
RETSAT;ADH1C;CYP2C8;...
|
